Cat. #161698
Anti-CD45R monoclonal antibody [GRT2]
Cat. #: 161698
Sub-type: Primary antibody
Target: CD45
Class: Monoclonal
Application: FACS; IHC; ELISA; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot, Federico Garrido Torres-Puchol
Institute: Virgen de las Nieves University Hospital, The Andalusian Health Service
Primary Citation: Ruiz-Cabello. 1989. Hybridoma. 8(1):1-11. PMID: 2466763
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CD45R monoclonal antibody [GRT2]
- Cancer: Blood cancer
- Research fields: Cancer
- Clone: GRT2
- Tool sub type: Primary antibody
- Class: Monoclonal
- Molecular weight: 95 kDa
- Reactivity: Human
- Host: Mouse
- Application: FACS; IHC; ELISA; WB
- Description: The unrestricted CD45 leukocyte common antigen (LCA) consists of an extracellular, membrane-proximal sequence that is common to all CD45 isoforms. All monoclonal antibodies belonging to the CD45 grouping react with this part of the antigen and can recognise all CD45 isoforms. The unrestricted CD45 epitope is present on the surface of all human leukocytes, lymphocytes, monocytes, eosinophils, basophils and neutrophils, in order of decreasing level of expression. It is not present on erythrocytes or platelets. GRT2 is a mouse monoclonal antibody of the IgG1 isotype.
- Immunogen: B-ALL cells
- Isotype: IgG1k
- Recommended controls: Leukocytes
Target Details
- Target: CD45
- Molecular weight: 95 kDa
Applications
- Application: FACS; IHC; ELISA; WB
Handling
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Ruiz-Cabello. 1989. Hybridoma. 8(1):1-11. PMID: 2466763
- Heulin et al. 1988. Br J Haematol. 69(2):173-179. PMID: 2968811
